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Phylogenomic analysis of Neisseria gonorrhoeae transmission 
to assess sexual mixing and HIV transmission risk in England: 
a cross-sectional, observational, whole-genome sequencing 
study
Katy Town, Nigel Field, Simon R Harris, Leonor Sánchez-Busó, Michelle J Cole, Rachel Pitt, Helen Fifer, Hamish Mohammed, Gwenda Hughes
Summary
Background Characterising sexual networks with transmission of sexually transmitted infections might allow 
identification of individuals at increased risk of infection. We aimed to investigate sexual mixing in Neisseria gonorrhoeae 
transmission networks between women, heterosexual men, and men who report sex with men (MSM), and between 
people with and without HIV.
Methods In this cross-sectional observational study, we whole-genome sequenced N gonorrhoeae isolates from the 
archive of the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP).w Isolates that varied by 
five single nucleotide polymorphisms or fewer were grouped into clusters that represented sexual networks with 
N gonorrhoeae transmission. Clusters were described by gender, sexual risk group, and HIV status.
Findings We sequenced 1277 N gonorrhoeae isolates with linked clinical and sociodemographic data that were collected 
in five clinics in England during 2013–16 (July 1 to Sept 30 in 2013–15; July 1 to Sept 9 in 2016). The isolates grouped 
into 213 clusters. 30 (14%) clusters contained isolates from heterosexual men and MSM but no women and three (1%) 
clusters contained isolates from only women and MSM. 146 (69%) clusters comprised solely people with negative or 
unknown HIV status and seven (3%) comprised only HIV-positive people. 60 (28%) clusters comprised MSM with 
positive and negative or unknown HIV status.
Interpretation N gonorrhoeae molecular data can provide information indicating risk of HIV or other sexually 
transmitted infections for some individuals for whom such risk might not be known from clinical history. These 
findings have implications for sexual health care, including offering testing, prevention advice, and preventive 
treatment, such as HIV pre-exposure prophylaxis.
Funding National Institute for Health Research Health Protection Research Unit; Wellcome; Public Health England.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 
4.0 license.
Introduction
Gonorrhoea, caused by the bacterium Neisseria gono­
rrhoeae, is an urgent threat to public health because of 
the development of antimicrobial resistance and 
impending threat of untreatable infections. Although 
rare in the general population,1 diagnoses of N gonorrhoeae 
infection have risen substantially in England in the past 
decade, primarily among men who report sex with men 
(MSM).2 N gonorrhoeae is concentrated in sexual networks 
wherein network members report high numbers of 
previous partners and concurrent sexual partnerships.3 
In the UK, some young adults, MSM, and people of black 
Caribbean ethnicity are at particular risk.2 Assortative 
sexual mixing might also concentrate infection in these 
groups, whereas disassortative sexual mixing fosters 
wider dissemination of infection across the population.3
Compared with women and men who have sex 
exclusively with women, MSM are more likely to engage 
in sexual behaviour that puts them at risk of sexually 
transmitted infections (STIs), including condomless 
sex with multiple sexual partners.4 MSM living with 
HIV have the highest rates of N gonorrhoeae diagnoses,5 
possibly linked to the adoption of HIV seroadaptive 
beha viours that accentuate STI risk, especially 
condomless anal sex.6,7 Among MSM without HIV, 
N gonorrhoeae infection is a strong predictor of sub­
sequent HIV infection.8
Characterising sexual networks and understanding 
sexual mixing patterns that facilitate N gonorrhoeae 
transmission can help predict and explain the dis­
tribution of infection in the population and might 
allow the identification of individuals at risk of other 
STIs, such as HIV and hepatitis A and B.9, However, 
sexual network analysis is complicated by uncontactable 
cases and incomplete epidemiological data, even after 
inten sive contract tracing.10 Collecting information 
about socially sensitive behaviours, such as sexual 
behaviour, can be subject to reporting bias, and 
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people with shared epi demiological characteristics or 
risk behaviours might not necessarily share a sexual 
network.
Phylogenomic analysis can resolve some of the uncer­
tainties in epidemiological investigations by differen­
tiating genetically related clusters of infections, which 
probably belong to a shared sexual network. Incorporating 
epidemiological and sexual behaviour data into phylo­
genetic analyses can thus provide insight into sexual 
mixing patterns and related public health implications. 
Studies of HIV and hepatitis B have identified sexual 
networks of MSM that include men who report exclu­
sively female partners.11,12
Phylogenomic analysis of N gonorrhoeae with linked 
epidemiological data has been used to map the spread of 
antimicrobial resistance across sexual networks and 
between countries and investigate the characteristics 
of N gonorrhoeae transmission chains.13–21 However, few 
studies have included sufficient clinical and sexual 
behaviour data to explore sexual mixing patterns 
between different sociodemographic groups and how 
mixing might influence STI and HIV transmission 
risk.22
To inform public health infection control efforts, we 
whole­genome sequenced more than 1200 N gonorrhoeae 
isolates with linked clinical and sociodemographic 
data collected in five sexual health clinics in England 
over a 4­year period. We investigated sexual mixing in 
N gonorrhoeae transmission networks between MSM, 
men reporting heterosexual behaviours, and women, 
and between MSM with and without HIV.
Methods
Isolate sampling
For this cross­sectional observational study, N gonorrhoeae 
isolates were obtained from the archive of the Gonococcal 
Resistance to Antimicrobials Surveillance Programme 
(GRASP).23 GRASP is a sentinel programme that tests 
Research in context
Evidence before this study
Our previous systematic review of studies published up to 
March 31, 2017, which investigated the use of molecular 
epidemiology for understanding the transmission of 
Neisseria gonorrhoeae in sexual networks found that few 
whole-genome sequencing (WGS) studies used broad sampling 
strategies and had sufficient patient information to investigate 
and describe sexual networks with N gonorrhoeae transmission. 
To update that review, we searched PubMed using the terms 
“Neisseria gonorrhoeae” OR “gonorrh*” AND “molecular 
epidemiology” for papers published up to March 31, 2019. 
Our search identified 26 studies. Nine studies used WGS, of 
which seven focused on the genetic determinants and spread 
of antimicrobial resistance in N gonorrhoeae. Six studies 
(three using WGS) only included isolates with a particular 
antimicrobial resistance phenotype or molecular strain type and 
provided sparse epidemiological information. A study from 
New Zealand that included 398 N gonorrhoeae isolates found a 
high frequency of sexual mixing between heterosexual or 
bisexual populations and men who report sex with men (MSM). 
A study from Brighton, UK, that included 100 isolates, 
predominantly from MSM, found that most sexual networks 
comprised people with differing HIV statuses. To our 
knowledge, no large WGS study including N gonorrhoeae 
isolates from multiple geographically dispersed sexual health 
clinics, people from various demographic and sexual behaviour 
groups, and across multiple years has been done in England.
Added value of this study
We did one of the largest molecular epidemiological studies of 
N gonorrhoeae to date, analysing WGS and epidemiological data 
from 1277 cases of N gonorrhoeae reported from five clinics in 
England between 2013 and 2016. To our knowledge, this study is 
the first to use WGS data to describe the sexual mixing patterns 
of women, heterosexual men, and MSM, and to identify the 
extent of sexual mixing between MSM with identical or different 
HIV statuses. We found that WGS data identified a considerable 
number of sexual networks containing men who report only 
heterosexual behaviours and MSM and extensive sexual mixing 
between MSM with HIV and those without or with unknown 
status. We showed that phylogenomic analyses provided 
additional information about sexual mixing patterns in 
N gonorrhoeae transmission networks that might not have been 
evident from epidemiological data alone.
Implications of all the available evidence
Reconstructing sexual networks from epidemiological data 
alone can be complicated because ascertaining whether 
individuals with similar reported characteristics share a sexual 
network can be difficult, and epidemiological data is often 
incomplete because of uncontactable individuals. By providing 
information about the sexual networks a patient belongs to 
and probable sexual health risks, real-time WGS data on 
N gonorrhoeae could influence clinical decision making and 
support tailored and relevant interventions. Sexual networks 
containing only isolates from heterosexual men and MSM 
suggest groups of heterosexual-identifying men might exist 
who could benefit from enhanced sexual health testing and 
prevention messages that would normally be targeted to MSM. 
Evidence of sexual mixing between MSM with HIV and those 
without HIV or with unknown status suggests that WGS could 
help identify men who might be at considerable and 
unrecognised risk of HIV infection. Such insights might improve 
prevention of HIV and other sexually transmitted infections by 
guiding decisions on preventive interventions, including HIV 
pre-exposure prophylaxis and hepatitis A and B testing and 
vaccination.
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antimicrobial susceptibility of consecutive isolates 
received from all culture­positive N gonorrhoeae diagnoses 
made between July 1, and Sept 30, 2013–15, and between 
July 1, and Sept 9, 2016, in 26 sexual health clinics in 
England and Wales. Since 2000, GRASP has collected 
1200–2500 isolates annually. Necessary for susceptibility 
testing, GRASP only includes N gonorrhoeae cultures, 
which are available for just under half of all gonorrhoea 
diagnoses in England.24 For this study, five GRASP clinics 
(two in London and one each in Birmingham, Bristol, 
and Liverpool) were selected to provide isolates that were 
broadly representative of people with gonorrhoea in 
England in terms of sociodemographic and behavioural 
characteristics, including gender, sexual risk group, age, 
ethnicity, and HIV status. Eligibility for sequencing was 
defined as all archived isolates from these clinics between 
2013 and 2016, which were the most recent years with 
available GRASP data.
Public Health England (PHE) has permission to process 
patient confidential data obtained by GRASP under 
Regulation 3 of the Health Service (Control of Patient 
Information) Regulations 2002. Information governance 
advice and ethics approval for this study were granted by 
the PHE Research Ethics and Governance Group.
Epidemiological data collection
The GRASP archive includes clinical, sociodemographic, 
and behavioural data collected through PHE’s STI sur­
veillance system (GUMCAD)25 and directly from parti­
cipating GRASP clinics. GUMCAD contains longitudinal 
patient records that enabled us to investigate whether 
people with a negative or unknown HIV status at the time 
of N gonorrhoeae diagnosis were subsequently diagnosed 
with HIV.
Isolation and whole-genome sequencing of isolates
Single colonies were isolated on non­selective GCVIT 
agar (Difco BBL GC II Agar Base plus 1% Vitox; Oxoid, 
Altrincham, UK). DNA was extracted from a subculture 
of a single colony of each isolate using the auto mated 
QIAsymphony DNA Mini Kit (Qiagen, Hilden, 
Germany). Whole­genome sequencing (WGS) was done 
at the Wellcome Sanger Institute (Hinxton, UK) with the 
Illumina HiSeq­X­Ten system and processed in the 
Sanger WGS data manage ment pipeline. Further details 
are described in appendix 1 (p 1) Sequence data are 
available on the European Nucleotide Archive with use of 
study accession identifier ERP022090. Metadata for 
sequences are provided in appendix 2.
Data analysis
To assess sample representativeness, we compared the 
epidemiological characteristics of the sequenced isolates 
with those of non­sequenced isolates (those that met 
study collection criteria but were not viable for 
sequencing) among all eligible study isolates and all 
gonorrhoea diagnoses in England from Jan 1, 2013, to 
Dec 31, 2016. Significant differences were assessed using 
a two­sample proportions Z test with a threshold for 
significance of 0∙05.
A phylogenetic tree with genetic recombination events 
removed was created using Gubbins (version 2.4.0)26 
with the RAxML tree building option (appendix 1 p 1) 
and the default GTR+gamma substitution model. The 
number of single nucleotide polymorphisms (SNPs) 
between each pair of isolates was estimated from the 
branch length distance, which was extracted from the 
phylogenetic tree using SeaView (version 4.7).27 Branch 
lengths are an estimate of the total number of sub­
stitutions that have occurred between a pair of isolates. 
To translate this estimate into an estimated SNP 
difference, the branch length was multiplied by the 
number of nucleotides in the sequence alignment that 
were used to create the phylogenetic tree.
The number of SNPs between each pair of isolates 
was used to define clusters of genetically similar isolates 
representing sexual networks with N gonorrhoeae trans­
mission. No standardised method exists to define a 
genetic cluster representing a sexual network. De Silva 
and colleagues14 predicted that isolates collected on the 
same day and up to nine SNPs apart and isolates collected 
within a year of each other and up to 14 SNPs apart might 
be part of the same transmission network. Studies by 
Fifer and colleagues17 and Kwong and colleagues19 found 
that the SNP difference between known contacts ranged 
from zero to five. We chose to group isolates into clusters 
using a SNP threshold of five or fewer SNPs, meaning 
that within a cluster each isolate must be no more than 
five SNPs different to at least one other isolate in the 
cluster. This SNP threshold was chosen as a conservative 
estimate for people who are closely linked within a sexual 








Only women 9 (4%) 20 0 0
Only heterosexual 
men
9 (4%) 0 18 0
Only MSM 108 (51%) 0 0 323
Only women and 
heterosexual men
49 (23%) 60 63 0
Only women and 
MSM
3 (1%) 3 0 3
Only heterosexual 
men and MSM




5 (2%) 8 8 8
Data are n or n (%). Heterosexual men were men who reported sexual activity 
exclusively with women. MSM=men who reported sex with men.
Table 1: Description of 213 clusters according to sexual risk group of 
isolates
See Online for appendix
For the European 
Nucleotide Archive see 
https://www.ebi.ac.uk/ena/data/
search?query=ERP022090
See Online for appendix 2
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of different thresholds on cluster size and potential 
implications for interpretation using threshold cutoffs of 
three or fewer, ten or fewer, and 14 or fewer SNPs 
(appendix 1 p 1).
Clusters were described by gender, HIV status, and 
sexual risk group, including all women, heterosexual 
men, and MSM (women who have sex exclusively with 
women were not considered as a separate group in this 
analysis because of small numbers). Univariate and 
multivariable analysis were used to assess differences in 
the epidemiological characteristics of people who were 
clustered with others from the same or different sexual 
risk groups. The epidemiological characteristics explored 
were diagnosis year, clinic location, age, ethnicity, 
country of birth, symptomatic infection, diagnosed with 
an STI (excluding HIV) in the previous year, number of 
sexual partners in the 3 months before diagnosis, and 
sex while travelling outside of the UK in the 3 months 
before diagnosis (herewith described as having travel­
associated sexual partnerships). Significance was 
assessed by whether the CI of the odds ratio (OR) 
included 1∙0 and whether the χ² p value was less than 
0∙05. A multivariable logistic regression model using a 
forward stepwise approach was developed including 
variables identified as being significantly associated with 
the outcome in the univariate model. The likelihood 
ratio test was used to assess whether explanatory 
variables should remain in the multivariable model, 
using a significance threshold of 0∙05. The same 
methods were used to assess differences between the 
epidemiological characteristics of clusters comprising 
only MSM with a negative or unknown HIV status and 
those comprising MSM with negative or unknown and 
positive HIV status. Missing data are reported in 
appendix 1 (p 2); records with missing data were not 
included in the analyses.
Role of the funding source
The funders of the study had no role in the study 
design, data collection, data analysis, data interpretation, 
or writing of the manuscript. The corresponding author 
had full access to all the data in the study and had 
final responsibility for the decision to submit for 
publication.
Results
1277 (91%) of 1407 eligible isolates were successfully 
sequenced. The remaining 130 (9%) isolates were not 
sequenced because the bacteria were no longer viable. 
Sequencing success was lower for isolates collected in 2016 
than for those from other years (251 [79%] of 319) in 2016, 
367 [92%] of 398 in 2015, 333 [97%] of 342 in 2014, and 
326 [94%] of 348 in 2013). Sequenced isolates represented 
21% of all 6184 GRASP isolates and 8–10% of all gonorrhoea 
diagnoses in each of the selected clinics during the study 
period: for the two London clinics, 186 (9%) of 1981 and 












OR (95% CI)* p value
Year†
2013 113 24 (30%) 89 (28%) 1·00 ··
2014 116 27 (34%) 89 (28%) 1·12 (0·60–2·10) 0·71
2015 121 22 (28%) 99 (31%) 0·82 (0·43–1·57) 0·56
2016 53 7 (9%) 46 (14%) 0·56 (0·22–1·42) 0·22
Clinic site
Outside of London 155 53 (66%) 102 (32%) 1·00 ··
London 248 27 (34%) 221 (68%) 0·23 (0·14–0·40)† <0·0001
Age (years)‡
≤24 80 13 (16%) 67 (21%) 1·00 ··
25–34 176 36 (45%) 140 (43%) 1·32 (0·66–2·67) 0·43
 ≥35 146 31 (39%) 116 (36%) 1·38 (0·67–2·82) 0·38
Ethnicity
White 279 69 (87%) 240 (76%) 1·00 ··
Black Caribbean 18 5 (6%) 13 (4%) 1·34 (0·46–3·89) 0·60
Black African 8 0 8 (3%) ·· ··
Black other 2 0 2 (<1%) ·· ··
Asian 15 1 (1%) 14 (4%) 0·25 (0·03–1·94) 0·15
Other 12 0 12 (4%) ·· ··
Mixed 32 4 (5%) 28 (9%) 0·50 (0·17–1·47) 0·20
Country of birth
UK 242 62 (78%) 180 (56%) 1·00 ··
Not UK 133 17 (21%) 116 (36%) 0·42 (0·23–0·77)§ 0·0035
Symptomatic infection¶
No 115 18 (26%) 97 (35%) 1·00 ··
Yes 235 52 (74%) 183 (65%) 1·53 (0·85–2·77) 0·16
Diagnosed with an STI (excluding HIV) in the previous year
No or unknown 268 60 (75%) 208 (65%) 1·00 ··




281 59 (74%) 222 (69%) 1·00 ··
Positive 122 21 (26%) 101 (31%) 0·78 (0·45–1·36) 0·38
Number of sexual partners in the 3 months before diagnosis‡
None 6 3 (5%) 3 (2%) 1·00 ··
One 63 21 (34%) 42 (27%) 0·50 (0·09–2·75) 0·42
Two or more 146 37 (61%) 109 (71%) 0·34 (0·06–1·78) 0·18
Travel-associated sexual partnership in the 3 months before diagnosis
No 195 54 (89%) 141 (92%) 1·00 ··
Yes 20 7 (12%) 13 (8%) 1·41 (0·53–3·72) 0·49
Data are n or n (%), unless otherwise indicated. Heterosexual men were men who reported sexual activity exclusively 
with women. MSM=men who reported sex with men. OR=odds ratio. STI=sexually transmitted infection. *Unadjusted 
ORs from univariate analyses, indicating the epidemiological characteristics of isolates from MSM who are more likely 
to cluster with isolates from heterosexual men and MSM than only isolates from MSM. †Adjusted OR 0·29 (95% CI 
0·17–0·52), p<0.0001 (adjusted for country of birth). ‡Results for tests for trend were p=0·19 for year, p=0·42 for age, 
and p=0·10 for sexual partners. §The association that was found for country of birth did not remain when adjusted for 
geographical location in the multivariable model (outside of London vs in London; adjusted OR 0·73 [95% CI 0·38–1·41], 
p=0·36). ¶Symptomatic infection was defined in the Gonococcal Resistance to Antimicrobials Surveillance Programme 
as discharge at any site or dysuria.
Table 2: Epidemiological characteristics of MSM who clustered with heterosexual men and other 
MSM versus those who clustered with MSM only
Articles
482 www.thelancet.com/infection   Vol 20   April 2020
for the three clinics outside of London, sequencing was 
done for 163 (10%) of 1682, 138 (8%) of 1812, and 404 (9%) 
of 4335 isolates, respectively. The sequenced isolates 
represented 1% (1277 of 146 369) of all gonorrhoea diagnoses 
in England during the study period (appendix 1 p 2). The 
1277 isolates came from 1256 people, of whom 1235 (98%) 
had one and 21 (2%) had two gonorrhoea diagnoses.
MSM were overrepresented in this study compared with 
N gonorrhoeae diagnoses nationally (766 [60%] of 1277 vs 
72 660 [50%] of 146 369; p<0∙0001). 226 (18%) of 
1277 participants were known to be living with HIV, 
compared with 16 171 (11%) of 146 369 people infected with 
gonorrhoea nationally (p<0∙0001). Few epidemiological 
data were missing (<10% for most variables; appendix 1 
p 2), although data on number of partners and travel­
associated partnerships were not available from one clinic 
in London.
We identified 213 clusters comprising 630 (49%) of 
1277 sequenced isolates, including 414 (54%) of 
766 isolates from MSM, 91 (44%) of 206 isolates from 
women, and 125 (41%) of 304 isolates from heterosexual 
men. Most clusters contained two isolates (135 [63%] of 
213; range of 2–21 isolates; appendix 1 p 7). Results from 
the sensitivity analysis showed minimal effect of various 
SNP thresholds on cluster size and description 
(appendix 1 pp 3, 4).
Among the 213 clusters, 108 (51%) only included isolates 
from MSM and 49 (23%) only included isolates from 
women and heterosexual men (table 1). A small percentage 
of clusters included only women, only heterosexual men, 
or isolates from all three sexual risk groups (table 1). 
30 (14%) clusters comprised isolates from heterosexual 
men and MSM but no women and three (1%) comprised 
only women and MSM (table 1). The 30 clusters of 
heterosexual men and MSM included the two largest 
clusters (comprising 21 and 11 isolates), which contained 
isolates from multiple years (appendix 1 p 5).
Of the 125 heterosexual men who clustered, 63 (50%) 
clustered with only women, 36 (29%) with only MSM, 
18 (14%) with only heterosexual men, and eight (6%) 
with MSM and women (table 1). There were no significant 
differences between the heterosexual men who clustered 
with only women and those who clustered with only 
MSM (appendix 1 p 6).
Of the 414 MSM who clustered, 323 (78%) clustered 
with only MSM, 80 (19%) with only heterosexual men, 
eight (2%) with women and heterosexual men, and 
three (1%) with only women (table 1). MSM who clustered 
with heterosexual men were less likely to be from a clinic 
in London and less likely to be born outside the UK than 
were those from MSM­only clusters (table 2). 
The association with country of birth did not remain 
after adjusting for geographical location (outside of 
London vs London).
146 (69%) of 213 clusters comprised only isolates from 
people with HIV­negative or HIV­unknown status and 
seven (3%) comprised only isolates from people with HIV 
(appendix 1 p 4). Each of the seven HIV­positive clusters 
contained only two isolates, all from MSM. 60 (28%) 
clusters comprised both people with HIV and people 
without HIV or with unknown HIV status. Of these 
60 clusters, 51 (85%) only contained isolates from MSM, 
eight (13%) included isolates from heterosexual men and 
MSM, and one (2%) contained only two isolates, both 
from hetero sexual men (figure; appendix 1 p 4). Within the 
eight clusters containing MSM and heterosexual men, 
Figure: Clusters of genetically similar Neisseria gonorrhoeae isolates, by sexual risk group and HIV status
Genetic similarity between isolates was defined as five or fewer single nucleotide polymorphisms. Image was 
created with the visualisation tool MicrobeTrace. (A) All clusters (213 in total, including 630 isolates). (B) Largest 
cluster, comprising 21 isolates. (C) Second largest cluster, comprising 11 isolates. MSM=men who reported sex 
with men.
Sexual risk group
       Heterosexual men
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which included the two largest clusters (appendix 1 p 5), 
21 (26%) of 80 MSM were HIV­positive and all 
36 heterosexual men were HIV­negative or had unknown 
HIV status.
Of the 292 MSM with HIV­negative or HIV­unknown 
status who clustered with other MSM, 124 (42%) clus­
tered with at least one HIV­positive MSM. MSM with 
negative or unknown HIV status who were diagnosed in 
a London clinic were more likely to be clustered with 
HIV­positive MSM than were those who were diagnosed 
outside of London (table 3). Clustering of MSM with 
negative or unknown HIV status with HIV­positive MSM 
was less likely to occur in 2016 than in 2013 (table 3).
In the longitudinal patient records held in GUMCAD, 
we observed that 33 (3%) of 1051 patients who were 
HIV­negative or had unknown HIV status at the time of 
gonorrhoea diagnosis were subsequently diagnosed with 
HIV. All were MSM and 25 (75%) were diagnosed within 
1 year of their gonorrhoea diagnosis. Patient follow­up 
varied between 3 months and 4 years because data were 
censored at the end of 2016. Among those diagnosed 
with HIV after gonorrhoea diagnosis, 17 (52%) clustered 
with others in the study and eight (24%) were in clusters 
containing isolates from both HIV­positive people and 
people with negative or unknown HIV status.
Discussion
This large molecular epidemiology study showed how 
sequencing data can be used to gain insights into sexual 
transmission networks transmitting STIs. Within a sample 
from England, we observed men who reported exclusively 
heterosexual behaviours who were part of sexual networks 
with MSM and many sexual networks comprising both 
HIV­positive MSM and MSM with negative or unknown 
HIV status. In both cases, the molecular data provided 
additional risk­profiling information indicating high risk 
of HIV and other blood­borne viruses, which might 
otherwise not be indicated from the patient’s clinical 
history. This information has implications for sexual 
health­care, including offering testing and prevention 
advice and management to people perceived to be at 
increased risk. Our findings complement existing evidence 
on sexual mixing and show the diversity and complexity of 
N gonorrhoeae sexual networks. Few WGS studies of 
N gonorrhoeae have benefited from clinical and behavioural 
data.21 To our knowledge, our study of N gonorrhoeae is the 
largest and most representative in England to date and one 
of the largest internationally. We sampled isolates from a 
geographically dispersed subset of clinics in England and 
although we found some significant differences between 
the characteristics of the study isolates and those of all 
gonorrhoea diagnoses in England, the absolute differences 
were small. Therefore, our study probably provides reliable 
insights into the molecular epidemiology of N gonorrhoeae 
in England.
The observed differences in patient characteristics 
between the study and national cases and the small sizes 
of clusters probably reflect a bias in the patient groups 
and isolates that were successfully cultured and the 
GRASP sampling frame.28 Just under 50% of isolates 
from gonorrhoea diagnoses in England are successfully 
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2013 56 29 (52%) 27 (48%) 1 ··
2014 60 26 (43%) 34 (57%) 1·37 (0·65–2·91) 0·41
2015 68 36 (53%) 32 (47%) 0·94 (0·46–1·95) 0·87
2016 38 29 (77%) 9 (24%) 0·33 (0·13–0·85) 0·021
Clinic location
Outside of London 86 59 (69%) 27 (31%) 1 ··
London 136 61 (45%) 75 (55%) 2·65 (1·47–4·74) 0·0007
Age, years‡
≤24 55 37 (67%) 18 (33%) ·· ··
25–34 104 52 (50%) 52 (50%) ·· ··
≥35 63 31 (49%) 32 (51%) ·· ··
Ethnicity
White 168 92 (55%) 76 (45%) ·· ··
Black Caribbean 4 1 (25%) 3 (75%) ·· ··
Black African 5 1 (20%) 4 (80%) ·· ··
Black other 1 1 (100%) 0 ·· ··
Asian 10 3 (30%) 7 (70%) ·· ··
Other 8 5 (63%) 3 (38%) ·· ··
Mixed 21 14 (67%) 7 (33%) ·· ··
Country of birth
UK 136 77 (57%) 59 (43%) ·· ··
Not UK 76 38 (50%) 38 (50%) ·· ··
Symptomatic infection§
No 67 37 (55%) 30 (45%) ·· ··
Yes 126 65 (52%) 61 (48%) ·· ··
Diagnosed with an STI (excluding HIV) in the previous year
No or unknown 161 90 (56%) 71 (44%) ·· ··
Yes 61 30 (49%) 31 (51%) ·· ··
Number of sexual partners in the 3 months before diagnosis‡
None 3 1 (33%) 2 (67%) ·· ··
One 32 19 (59%) 13 (41%) ·· ··
Two or more 89 51 (57%) 38 (43%) ·· ··
Travel-associated sexual partnership in the 3 months before diagnosis
No 113 63 (56%) 50 (44%) ·· ··
Yes 11 8 (73%) 3 (27%) ·· ··
Data are n or n (%), unless otherwise indicated. MSM=men who reported sex with men. STI=sexually transmitted 
infection. *Adjusted odds ratios from multivariable analyses are shown, indicating the epidemiological chracteristics of 
MSM with negative or unknown HIV status that cluster with HIV-positive MSM; results are adjusted for the association 
with clinic location and year of diagnosis. †The p-value for the likelihood ratio test for the overall association between 
the exposure (all categories) and the outcome was 0·0008. ‡Results for tests for trend were p=0·025 for year, p=0·057 
for age, and p=0·79 for sexual partners. §Symptomatic infection was defined in the Gonococcal Resistance to 
Antimicrobials Surveillance Programme as discharge at any site or dysuria.
Table 3: Epidemiological characteristics of MSM with negative or unknown HIV status who clustered 
with MSM with negative or unknown HIV status versus those who clustered with HIV-positive MSM
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from genital and symptomatic infections than from 
extragenital and asymptomatic infections and less likely 
to be successful from women and MSM than from 
heterosexual men.24 The poor availability of cultures, 
short period of data collection in GRASP (3 months 
per year), and inclusion of a small number of clinics also 
explain why most clusters identified in this study were 
small and 647 cultures did not cluster at all. As with all 
WGS studies of N gonorrhoeae, an entirely representative 
sample of the gonococcal population cannot be achieved 
given many infections are never diagnosed. Therefore, 
we were unable to fully explore the patterns of sexual 
mixing for underrepresented groups, especially women. 
Additionally, data on sexual behaviour, other than sexual 
risk group, were sparse; more detailed information 
collected in larger studies might improve the power to 
detect significant differences between people clustered in 
distinct groups.
The low proportion of re­infection in our study—only 
21 (2%) of 1256 people included in our study had more 
than one gonorrhoea diagnosis—was probably due to 
the restricted time period of GRASP, which means that 
reinfections occurring 4–9 months after the initial 
infection would not be captured in our study. Anyone 
attending a different sexual health clinic would also not 
be identified as a reinfection in our study because it is not 
possible to trace patients between clinics in GUMCAD
Although we could not distinguish between direct and 
indirect sexual transmission or establish the direction of 
transmission, the tight SNP threshold that was used to 
define clusters meant that people within the same cluster 
were likely to belong to the same recent transmission 
network. However, we could not confirm that our chosen 
SNP threshold truly identified closely linked cases within 
a sexual network as partner notification data were not 
available. As with other N gonorrhoeae studies, the high 
frequency of DNA recombination requires computational 
strategies to identify SNP differences arising through 
muta tion rather than recombination. We identified 
and removed recombinant DNA, but some probably 
remained, which might have led to incorrect inferences 
about relatedness for some isolates.
We found that mixed clusters of men reporting hetero­
sexual behaviour and MSM were considerably more 
common than those of MSM and women, which might 
provide evidence of sexual mixing between gay­identifying 
and heterosexual­identifying MSM. We also identified 
clusters containing only heterosexual men, which might 
represent a group of heterosexual­identifying men having 
sex with other heterosexual­identifying men. However, it 
is possible that heterosexual men and MSM were not 
directly linked but shared female partners who were 
underrepresented in this study because of difficulty in 
collecting cultures from women,24 which might also 
explain the small size of most clusters. We found no 
differences in epidemiological characteristics between 
heterosexual men clustering only with MSM and those 
clustering only with women. Another study has found 
that men in sexual networks with MSM who report only 
heterosexual behaviours are more likely to be of black 
African ethnicity.11 A British population­based survey 
found that of 190 men reporting a same­sex partner, 
54 (28%) identified as heterosexual.29 Where differences 
exist between identity and same­sex behaviour in men, 
public health and clinical practice interventions and 
messaging that target only MSM who identify as gay or 
bisexual might miss and even disenfranchise heterosexual­
identifying MSM.
We found some evidence of serosorting among MSM, 
as some N gonorrhoeae clusters only comprised people of 
the same HIV status. As seen in a previous study,21 a 
larger number of clusters comprised both MSM with 
HIV and those with negative or unknown HIV status, 
which is perhaps unsurprising given the inherent 
limitations of serosorting as an HIV risk­reduction 
strategy (ie, undiagnosed infections and misreporting of 
status).6,7 Even in small clusters of people with mixed HIV 
status, we were able to show subsequent HIV diagnoses 
among some MSM with HIV­negative or HIV­unknown 
status at gonorrhoea diagnosis.
Most epidemiological characteristics of MSM who 
were HIV­negative or HIV­unknown who clustered with 
HIV­positive MSM could not be distinguished from 
those who clustered only with other HIV­negative or 
HIV­unknown MSM. Increased availability and use 
of antiretroviral therapies, including treatment as 
prevention in HIV­positive and PrEP in HIV­negative 
MSM, might explain the sub stantial number of clusters 
of people with mixed HIV status. Sexual behaviours, 
specifically condom use, have probably been affected by 
the increase in HIV­positive MSM with an undetectable 
viral load and in PrEP use in HIV­negative MSM, which 
might lead to N gonorrhoeae but not HIV transmission. 
With reduced HIV transmission risk, HIV sero­adaptive 
behaviours might have declined or become more 
complex.
National guidelines for sexual health services vary for 
different populations according to their sexual and other 
risk behaviours. For example, MSM are routinely offered 
extra­genital testing for chlamydia and gonorrhoea and 
testing and vaccination for hepatitis A and B, whereas 
most heterosexual men are not offered such services.30 To 
choose the appropriate management strategy, clinicians 
often use self­reported behavioural data from patients to 
assess their risk. However, patients might be reluctant to 
report some sexual behaviours because of concerns 
about confidentiality and stigma, or they might not know 
that they belong to a sexual network that increases their 
risk of HIV and other blood­borne viruses.
Our findings suggest that sequencing data on 
N gonorrhoeae could, when combined with epide­
miological data, be used to improve understanding of a 
person’s sexual network and HIV and blood­borne virus 
risk. Although the absolute risk of infection transmission 
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could not be quantified in this study, if available in a 
clinically relevant timeframe, WGS data could provide 
insight into sexual risk profiles and support patient 
management, including extra­genital testing for 
chlamydia and gonorrhoea, HIV PrEP, testing and 
vaccination for hepatitis A and B, and behavioural risk­
reduction advice.
Implementation of WGS to support patient and partner 
risk management raises ethical issues about commu­
nication and interpretation of genomic data in an 
appropriately sensitive manner that takes account of 
patient confidentiality and safeguards to avoid deductive 
disclosure about transmission. Information derived from 
WGS data should be communicated to the patient without 
revealing specific details about the sexual network they are 
predicted to be a part of. Further research is needed 
to explore the ethical and patient communication issues 
around the use of WGS to inform clinical management.
Several practical and cost implications should be con­
sidered before WGS is implemented in this manner. 
Expansion of facilities and expertise is required to conduct 
WGS, analyse WGS data, and share WGS data between 
local and national health­care professionals. Results would 
need to be sufficiently prompt (<2 weeks) to enable clinical 
and public health decision making. Real­time WGS would 
require direct sequencing from urine or swabs rather than 
from culture to facilitate faster sample processing and 
better coverage.
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